SpinalCyte reports Phase I/II data for dermal fibroblast cell therapy

SpinalCyte LLC (Houston, Texas) reported data from a Phase I/II trial in 16 patients with chronic lower back pain caused by degenerative disc disease showing that a single intradiscal injection of 10 million cells of CybroCell improved Oswestry Disability Index (ODI) score by >15 points in four of six patients vs. one of four patients who received CybroCell plus platelet-rich plasma and one of six patients who received saline...